Distinguishing between expert and statistical systems for application under ICH M7

Regulatory Toxicology and Pharmacology

Volumn 84, Issue , 2017, Pages 124-130

  Barber, Chris ^a   Hanser, Thierry ^a   Judson, Philip ^b   Williams, Richard ^a  

^a LHASA LIMITED   (United Kingdom)

^b Heather Lea Bland Hill Norwood   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORONIC ACID DERIVATIVE; MUTAGENIC AGENT;

ALGORITHM; CANCER RISK; COMPUTER ANALYSIS; DRUG CONTROL; DRUG IMPURITY; DRUG QUALITY; EXPERT SYSTEM; KNOWLEDGE BASE; NOTE; PRACTICE GUIDELINE; QUALITY CONTROL; RISK REDUCTION; STATISTICAL ANALYSIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; COMPUTER SIMULATION; DRUG CONTAMINATION; HUMAN; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; MUTAGEN TESTING; PATIENT SAFETY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANIMALS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DRUG AND NARCOTIC CONTROL; DRUG CONTAMINATION; EXPERT SYSTEMS; HUMANS; MODELS, STATISTICAL; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; MUTAGENS; PATIENT SAFETY; POLICY MAKING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 85009458357     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2016.12.012     Document Type: Note

References (32)

1. Ahlberg, E., Amberg, A., Beilke, L.D., Bower, D., Cross, K.P., Custer, L., Ford, K.A., Van Gompel, J., Harvey, J., Honma, M., Jolly, R., Joossens, E., Kemper, R.A., Kenyon, M., Kruhlak, N., Kuhnke, L., Leavitt, P., Naven, R., Neilan, C., Quigley, D.P., Shuey, D., Spirkl, H.-P., Stavitskaya, L., Teasdale, A., White, A., Wichard, J., Zwickl, C., Myatt, G.J., Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: a case study using aromatic amine mutagenicity. Regul. Toxicol. Pharmacol. 77 (2016), 1–12, 10.1016/j.yrtph.2016.02.003.
2. Amberg, A., Beilke, L., Bercu, J., Bower, D., Brigo, A., Cross, K.P., Custer, L., Dobo, K., Dowdy, E., Ford, K.A., Glowienke, S., Gompel, J., van Harvey, J., Hasselgren, C., Honma, M., Jolly, R., Kemper, R., Kenyon, M., Kruhlak, N., Leavitt, P., Miller, S., Muster, W., Nicolette, J., Plaper, A., Powley, M., Quigley, D.P., Reddy, M.V., Spirkl, H.-P., Stavitskaya, L., Teasdale, A., Weiner, S., Welch, D.S., White, A., Wichard, J., Myatt, G.J., Ward, J.K., Taylor, R.E., Southon, J.R., Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses. Regul. Toxicol. Pharmacol. 22 (2016), 85–98, 10.1016/j.yrtph.2016.02.004.
3. Amberg, A., Harvey, J.S., Czich, A., Spirkl, H.-P., Robinson, S., White, A., Elder, D.P., Do carboxylic/sulfonic acid halides really present a mutagenic and carcinogenic risk as impurities in final drug products?. 150715095425004 Org. Process Res. Dev., 2015, 10.1021/acs.oprd.5b00106.
4. Araya, S., Barle, E.L., Glowienke, S., Mutagenicity Assessment Strategy for Pharmaceutical Intermediates to aid limit setting for occupational exposure. Regul. Toxicol. Pharmacol. 73 (2015), 515–520, 10.1016/j.yrtph.2015.10.001.
5. Ball, N., Cronin, M.T.D., Shen, J., Blackburn, K., Booth, E.D., Bouhifd, M., Donley, E., Egnash, L., Hastings, C., Juberg, D.R., Kleensang, A., Kleinstreuer, N., Kroese, E.D., Lee, A.C., Luechtefeld, T., Maertens, A., Marty, S., Naciff, J.M., Palmer, J., Pamies, D., Penman, M., Richarz, A.N., Russo, D.P., Stuard, S.B., Patlewicz, G., Van Ravenzwaay, B., Wu, S., Zhu, H., Hartung, T., Toward good read-across practice (GRAP) guidance. ALTEX 33 (2016), 149–166, 10.14573/altex.1601251.
6. Barber, C., Amberg, A., Custer, L., Dobo, K.L., Glowienke, S., Van Gompel, J., Gutsell, S., Harvey, J., Honma, M., Kenyon, M.O., Kruhlak, N., Muster, W., Stavitskaya, L., Teasdale, A., Vessey, J., Wichard, J., Establishing best practise in the application of expert review of mutagenicity under ICH M7. Regul. Toxicol. Pharmacol. 73 (2015), 367–377, 10.1016/j.yrtph.2015.07.018.
7. Barber, C., Cayley, A., Hanser, T., Harding, A., Heghes, C., Vessey, J.D., Werner, S., Weiner, S.K., Wichard, J., Giddings, A., Glowienke, S., Parenty, A., Brigo, A., Spirkl, H.-P., Amberg, A., Kemper, R., Greene, N., Evaluation of a statistics-based ames mutagenicity QSAR model and interpretation of the results obtained. Regul. Toxicol. Pharmacol. 76 (2016), 7–20, 10.1016/j.yrtph.2015.12.006.
8. Benfenati, E., Diaza, R.G., Cassano, A., Pardoe, S., Gini, G., Mays, C., Knauf, R., Benighaus, L., The acceptance of in silico models for REACH: requirements, barriers, and perspectives. Chem. Cent. J., 5, 2011, 58, 10.1186/1752-153X-5-58.
9. Benigni, R., Bossa, C., Jeliazkova, N., Netzeva, T., Worth, A., The Benigni / Bossa rulebase for mutagenicity and carcinogenicity – a module of Toxtree. Eur. Comm. Rep. EUR 23241 https://eurl-ecvam.jrc.ec.europa.eu/laboratories-research/predictive_toxicology/doc/EUR_23241_EN.pdf, 2008.
10. Cherkasov, A., Muratov, E.N., Fourches, D., Varnek, A., Baskin, I.I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y.C., Todeschini, R., Consonni, V., Kuz'min, V.E., Cramer, R., Benigni, R., Yang, C., Rathman, J., Terfloth, L., Gasteiger, J., Richard, A., Tropsha, A., QSAR modeling: where have you Been? Where are you going to?. J. Med. Chem. 57 (2014), 4977–5010, 10.1021/jm4004285.
11. Dearden, J.C., Cronin, M.T.D., Kaiser, K.L.E., How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR). SAR QSAR Environ. Res. 20 (2009), 241–266, 10.1080/10629360902949567.
12. Dobo, K.L., Greene, N., Fred, C., Glowienke, S., Harvey, J.S., Hasselgren, C., Jolly, R., Kenyon, M.O., Munzner, J.B., Muster, W., Neft, R., Reddy, M.V., White, A.T., Weiner, S., In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey. Regul. Toxicol. Pharmacol. 62 (2012), 449–455, 10.1016/j.yrtph.2012.01.007.
13. Greene, N., Dobo, K.L., Kenyon, M.O., Cheung, J., Munzner, J., Sobol, Z., Sluggett, G., Zelesky, T., Sutter, A., Wichard, J., A practical application of two in silico systems for identification of potentially mutagenic impurities. Regul. Toxicol. Pharmacol. 72 (2015), 335–349, 10.1016/j.yrtph.2015.05.008.
14. Hanser, T., Barber, C., Rosser, E., Vessey, J.D., Webb, S.J., Werner, S., Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge. J. Cheminform, 6, 2014, 21, 10.1186/1758-2946-6-21.
15. Hayashi, M., Kamata, E., Hirose, A., Takahashi, M., Morita, T., Ema, M., In silico assessment of chemical mutagenesis in comparison with results of Salmonella microsome assay on 909 chemicals. Mutat. Res. - Genet. Toxicol. Environ. Mutagen 588 (2005), 129–135, 10.1016/j.mrgentox.2005.09.009.
16. Jolly, R., Begam, K., Ahmed, R., Zwickl, C., Watson, I., Gombar, V., An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment. Regul. Toxicol. Pharmacol. 71 (2015), 388–397, 10.1016/j.yrtph.2015.01.010.
17. Judson, P., Knowledge-based Expert Systems in Chemistry, RSC Theoretical and Computational Chemistry Series. 2009, Royal Society of Chemistry, Cambridge, 10.1039/9781847559807.
18. Judson, P.N., Marchant, C.A., Vessey, J.D., Using argumentation for absolute reasoning about the potential toxicity of chemicals. J. Chem. Inf. Comput. Sci. 43 (2003), 1364–1370, 10.1021/ci020272g.
19. Judson, P.N., Stalford, S.A., Vessey, J., Assessing confidence in predictions made by knowledge-based systems. Toxicol. Res. (Camb) 44 (2013), 70–79, 10.1039/c2tx20037f.
20. Judson, P.N., Vessey, J.D., A comprehensive approach to argumentation. J. Chem. Inf. Comput. Sci. 43 (2003), 1356–1363, 10.1021/ci020271o.
21. Lewis, R.A., Wood, D., Modern 2D QSAR for drug discovery. Wiley Interdiscip. Rev. Comput. Mol. Sci., 2014, 10.1002/wcms.1187.
22. M7 step 4, Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk [WWW Document]. URL, 2014 http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Step_4.pdf (accessed 3.18.15).
23. Marchant, C.A., Briggs, K.A., Long, A., In silico tools for sharing data and knowledge on toxicity and metabolism: Derek for windows, meteor, and vitic. Toxicol. Mech. Methods 18 (2008), 177–187, 10.1080/15376510701857320.
24. OECD, Guidance Document on the Validation of (Quantitative) Structure-activity Relationship [QSAR] Models. URL, 2007, Environment Health and Safety Publications Series on Testing and Assessment [WWW Document] http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?doclanguage=en%26cote=env/jm/mono(2007)2.
25. Powley, M.W., (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission. Regul. Toxicol. Pharmacol. 71 (2015), 295–300, 10.1016/j.yrtph.2014.12.012.
26. Roberts, D.W., Aptula, A., Schultz, T.W., Shen, J., Api, A.M., Bhatia, S., Kromidas, L., A practical guidance for cramer class determination. Regul. Toxicol. Pharmacol., 2015, 10.1016/j.yrtph.2015.09.017.
27. Sutter, A., Amberg, A., Boyer, S., Brigo, A., Contrera, J.F., Custer, L.L., Dobo, K.L., Gervais, V., Glowienke, S., van Gompel, J., Greene, N., Muster, W., Nicolette, J., Reddy, M.V., Thybaud, V., Vock, E., White, A.T., Müller, L., Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regul. Toxicol. Pharmacol. 67 (2013), 39–52, 10.1016/j.yrtph.2013.05.001.
28. Teasdale, A., Regulatory highlights. Org. Process Res. Dev. 19 (2015), 494–498, 10.1021/acs.oprd.5b00085.
29. Tripathi, K.P., A review on knowledge-based expert System: concept and architecture. Artif. Intell. Tech. - Nov. Approaches Pract. Appl. 4 (2011), 19–23, 10.5120/2845-226.
30. Varnek, A., Baskin, I., Machine learning methods for property prediction in chemoinformatics: quo Vadis. J. Chem. Inf. Model 52 (2012), 1413–1437, 10.1021/ci200409x.
31. Williams, R.V., Amberg, A., Brigo, A., Coquin, L., Giddings, A., Glowienke, S., Greene, N., Jolly, R., Kemper, R., O'Leary-Steele, C., Parenty, A., Spirkl, H.-P., Stalford, S.A., Weiner, S.K., Wichard, J., It's difficult, but important, to make negative predictions. Regul. Toxicol. Pharmacol. 76 (2016), 79–86, 10.1016/j.yrtph.2016.01.008.
32. Worth, A.P., Cronin, M.T., The use of bootstrap resampling to assess the uncertainty of cooper statistics. Altern. Lab. Anim 29 (2001), 447–459.